Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Tobacco smoke - Cigarette smoking

5

I.h Subclinical pulmonary infiltrates/ILD

5
Last update : 09/08/2013
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
E-cigarette - E-vaporizers - ENDS - Vaping - Dabbing
5
Vaping
5

Publications

Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
Radiology 2013 Aug;268;563-71 2013 Aug
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.
American journal of respiratory and critical care medicine 2012 Mar 01;185;547-56 2012 Mar 01
Subclinical interstitial lung disease: why you should care.
American journal of respiratory and critical care medicine 2012 Jun 01;185;1147-53 2012 Jun 01

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies